Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport SystemBusiness Wire • 06/17/25
Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport SystemBusiness Wire • 03/19/25
Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial GuidanceBusiness Wire • 02/25/25
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal ConferenceBusiness Wire • 02/17/25
Bronstein, Gewirtz & Grossman, LLC Encourages Orthofix Medical Inc. (OFIX) Investors to Inquire about Securities InvestigationAccesswire • 12/04/24
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!GlobeNewsWire • 11/08/24
FINAL REMINDER OFIX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Orthofix Medical Inc. Investors to Participate in the Class Action Lawsuit!Accesswire • 11/08/24
OFIX INVESTORS: OrthoFix Medical Inc. Stockholders Should Contact Robbins LLP About Joining the Pending OFIX Class ActionPRNewsWire • 11/07/24
Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial TargetsBusiness Wire • 11/07/24
FINAL OFIX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Orthofix Medical Inc. Investors to Join the Class Action Lawsuit!Accesswire • 11/07/24
OFIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Orthofix Medical Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 11/06/24
OFIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Orthofix Medical Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 11/05/24